(Albany, NY) DelveInsight launched its new report on Ataxia Telangiectasia (AT) – Market Insights, Epidemiology, and Market Forecast-2030
DelveInsight’s “Ataxia Telangiectasia (AT) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Ataxia Telangiectasia (AT), historical and forecasted epidemiology as well as the Ataxia Telangiectasia (AT) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the report:1. Ataxia Telangiectasia occurs in 1 in 40,000–100,000 people worldwide.2. Males and females are affected in equal numbers. In the United States, the prevalence is approximately 1 in 40,000–100,000 live births.3. In the United States, about one per cent of the population is a carrier of a mutation in the Ataxia Telangiectasia mutated kinase (ATM) gene.4. The average Ataxia Telangiectasia prevalence is 1 per 100,000 children. The most reliable estimates for the number of people with Ataxia Telangiectasia, in the UK at least are 3 per million.
Key benefits of the report:1. Ataxia Telangiectasia market report covers a descriptive overview and comprehensive insight of the Ataxia Telangiectasia epidemiology and Ataxia Telangiectasia market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)2. Ataxia Telangiectasia market report provides insights on the current and emerging therapies.3. Ataxia Telangiectasia market report provides a global historical and forecasted market covering drug outreach in 7 MM.4. Ataxia Telangiectasia market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Ataxia Telangiectasia market.
The key players in Ataxia Telangiectasia market are:1. EryDel2. IntraBioThe launch of the emerging therapies is expected to significantly impact Ataxia Telangiectasia treatment scenario in the upcoming years:-
Drugs covered:1. EryDex System2. IB1001
Table of contents:1. Report Introduction2. Ataxia Telangiectasia Market Overview at a Glance3. Ataxia Telangiectasia Executive Summary4. Ataxia Telangiectasia SWOT5. Ataxia Telangiectasia Disease Background and Overview6. Ataxia Telangiectasia Epidemiology and Patient Population6.1. Assumptions and Rationale6.2. 7MM Prevalent cases of Ataxia Telangiectasia (2017–2030)6.3. Diagnosed Cases of Ataxia Telangiectasia (2017–2030)6.4. Treatable Cases of Ataxia Telangiectasia (2017–2030)6.5. Ataxia Telangiectasia Country- Wise Epidemiology6.6. United States6.7. EU-56.8. Assumptions and Rationale6.9. Germany6.10. France6.11. Italy6.12. Spain6.13. United Kingdom6.14. Japan7. Ataxia Telangiectasia Current Therapies8. Ataxia Telangiectasia Emerging Therapies9. Key Cross Competition9.1. EryDex System: EryDel9.2. IB1001: IntraBio10. Ataxia Telangiectasia Market Size11. 7MM Ataxia Telangiectasia Country-Wise Market Analysis12. United States Market Size13. Germany Market Size14. France Market Size15. United Kingdom Market Size16. Spain Market Size17. Italy Market Size18. Japan Market Size19. Market Drivers20. Market Barriers21. Ataxia Telangiectasia Report Methodology22. DelveInsight Capabilities23. Disclaimer24. About DelveInsight
Related reports:
Ataxia Telangiectasia (AT) – Epidemiology Forecast to 2030
Ataxia – Epidemiology Forecast to 2030
Ataxia – Market Insights, Epidemiology, and Market Forecast-2030
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/